DHODH and systemic lupus erythematosus: Subsequently, multiple research teams independently reported that DHODH inhibitor Vi has therapeutic effects on various diseases, including systemic lupus erythematosus, inflammatory bowel disease, renal transplantation rejection reaction, and relapsing–remitting multiple sclerosis [38, 39, 41, 42].